Clinical trial
S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients…
NCT00045630 · SWOG Cancer Research Network, Other · Completed
Key facts
| NCT number | NCT00045630 |
|---|---|
| Title | S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the Urothelium |
| Official title | A Sequential Approach to the Treatment of Muscle Invasive, Non-Metastatic Urothelial Carcinoma of the Bladder: A Phase II Trial of Neoadjuvant Gemcitabine, Paclitaxel and Carboplatin With Molecular Correlates |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer |
| Intervention type | Drug, Procedure |
| Interventions | carboplatin, gemcitabine, paclitaxel, surgery |
| Enrollment | 77 |
| Start date | Jan 1, 2003 |
| Primary completion | May 1, 2008 |
| Completion | Dec 1, 2011 |
| First posted | Jan 27, 2003 |
| Last update posted | May 27, 2013 |
| Countries | United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: